BILL NUMBER: AB 1277	INTRODUCED
	BILL TEXT


INTRODUCED BY   Assembly Members Hill and Perea

                        FEBRUARY 18, 2011

   An act relating to business.


	LEGISLATIVE COUNSEL'S DIGEST


   AB 1277, as introduced, Hill. Biotechnology industry: regulation.
   Existing law creates various state agencies and authorizes certain
of those agencies to regulate the operations of businesses.
   This bill would make findings and declarations of the Legislature
and state the intent of the Legislature to adopt legislation that
would reduce regulatory redundancies impacting the biotechnology
industry.
   Vote: majority. Appropriation: no. Fiscal committee: no.
State-mandated local program: no.


THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:

  SECTION 1.  (a) The Legislature finds and declares both of the
following:
   (1) There are over 2,200 companies and more than 267,000 employees
statewide in the biotechnology industry. It is imperative that
government agencies do not unnecessarily hinder this unique
California industry, which added 12,000 jobs between 2005 and 2009.
   (2) According to the 2011 California Biomedical Industry Report,
68 percent of chief executive officers said they expected to expand
the overall size of their workforce within California. For the first
time in the report's 17-year history, nearly twice as many biomedical
chief executive officers said they intend to increase manufacturing
within California, 41 percent, compared to out-of-state, 21 percent,
over the next two years. In addition, 62 percent of chief executive
officers surveyed said they expect to expand research and development
within California.
   (b) It is the intent of the Legislature to enact legislation that
would reduce regulatory redundancies impacting the biotechnology
industry in California.